In the media 9 Jan 2025 Pourquoi les derniers cas de maladie du sommeil seront les plus difficiles à éliminer ? Nature
Scientific articles 10 Jan 2025 Congenital Chagas disease: A cohort study to assess molecular diagnostic methods at the Chagas disease national reference center of Argentina PLOS Neglected Tropical Diseases
In the media 9 Jan 2025 Why the last cases of sleeping sickness will be the hardest to eliminate Nature
In the media 6 Jan 2025 We asked global thinkers how to improve life on earth in 2025. Here are their wishes NPR
Scientific articles 20 Dec 2024 Challenges of sharing individual participant data for secondary research on neglected tropical diseases: the experience of Drugs for Neglected Diseases initiative and a call for action BMJ Open
News 19 Dec 2024 Message on the passing of Dr Yves Champey from DNDi Executive Director Dr Luis Pizarro
In the media 11 Dec 2024 «Pour convaincre le capital privé d’investir en faveur de la nature, il faut lui offrir des options de sortie» Agefi
In the media 9 Dec 2024 Interview de Laurent Fraisse sur les besoins pédiatriques liés aux maladies tropicales négligées RFI Priorité Santé
Scientific articles 15 Aug 2024 A standardized clinical database for research in Chagas disease: The NHEPACHA network PLOS Neglected Tropical Diseases
Scientific articles 15 Aug 2024 Paving the way for affordable and equitable liposomal amphotericin B access worldwide The Lancet Global Health
Scientific articles 8 Aug 2024 The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis Trends in Parasitology
Scientific articles 5 Aug 2024 How do we classify organ involvement in Chagas disease? A systematic review of organ involvement since 1909, highlighting the urgent need for a universal classification system in chronic Chagas disease PLOS Neglected Tropical Diseases
Scientific articles 1 Aug 2024 Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial Lancet Infectious Diseases
Scientific articles 15 Jul 2024 Differences in the cellular immune response during and after treatment of Sudanese patients with post-kala-azar dermal leishmaniasis, and possible implications for outcome Journal of Epidemiology and Global Health
Scientific articles 15 Jul 2024 Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements Wellcome Open Research
Scientific articles 2 Jul 2024 Design, conduct, analysis, and reporting of therapeutic efficacy studies in visceral leishmaniasis: A systematic review of published reports, 2000–2021 American Journal of Tropical Medicine and Hygiene
Scientific articles 20 Jun 2024 A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh PLOS Neglected Tropical Diseases
Scientific articles 31 May 2024 Demystifying in vivo bioluminescence imaging of a Chagas disease mouse model for drug efficacy studies Journal of Visualized Experiments
Scientific articles 21 May 2024 Modular and divergent synthesis of 2,N3-disubstituted 4-quinazolinones facilitated by regioselective N-alkylation Organic and Biomolecular Chemistry
Scientific articles 20 May 2024 Population pharmacokinetics of ravidasvir in adults with chronic hepatitis C virus infection and impact of antiretroviral treatment Antimicrobial Agents and Chemotherapy
Scientific articles 16 May 2024 Chagas disease in the United States: a call for increased investment and collaborative research The Lancet Regional Health – Americas
Scientific articles 13 May 2024 Synthesis and anti-Trypanosoma cruzi activity of 3-cyanopyridine derivatives ACS Omega
Scientific articles 11 May 2024 In vivo bioluminescence imaging reveals differences in Leishmania infantum parasite killing kinetics by antileishmanial reference drugs ACS Infectious Diseases
Scientific articles 10 May 2024 Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia Journal of Antimicrobial Chemotherapy
